公开(公告)号：US20210024907A1

公开(公告)日：2021-01-28

申请号：US17041787

申请日：2019-03-27

Applicant: Factor Bioscience Inc.

Inventor： Matthew ANGEL ,  Christopher ROHDE ,  Simon MOORE ,  Franklin KOSTAS ,  Jasmine HARRIS

IPC: C12N9/22 ,  A61K9/127 ,  C07K14/50 ,  C07K14/54 ,  A61P37/06 ,  A61P25/00

Abstract: The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices.

公开(公告)号：US20240182856A1

公开(公告)日：2024-06-06

申请号：US18461368

申请日：2023-09-05

Applicant: Factor Bioscience Inc.

Inventor： Matthew ANGEL ,  Christopher ROHDE ,  Mitchell KOPACZ ,  Jasmine HARRIS ,  James PAN

IPC: C12N5/0783 ,  C12N15/10

CPC classification number: C12N5/0646 ,  C12N15/102 ,  C12N2506/1307 ,  C12N2510/00

Abstract: The present disclosure relates in part to engineered immune cells that are, inter alia, silenced from a host immune response.